This expansion announcement came right after raising series B funding of $27 Mn in a round led by Fundamentum Partnership, earlier this month.
Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
This agreement is in addition to the $92 million filling line expansion announced in November 2021
Pharmaceutical manufacturer uses Veeam solutions to accelerate mission-critical backups by 95% and restore data in minutes, not hours
OS-SiA is the industry’s first AI-enabled digital scanner that will provide real-time predictive analysis and actionable insights
The ABDM public dashboard is a one-stop solution for information on the mission’s progress up to state/UT level
Already an existing partner and supplier of ingredients to Medisca, striking this agreement with SUANFARMA involved reinforcing a well-established symbiotic relationship between two companies committed to world-class quality, service, and price
The company’s annual sales grew from Rs 548.12 crore in FY 2020-21 to Rs 598.65 crore this fiscal
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
Data from the three studies formed the basis of the company's application for approval by regulatory agencies
Subscribe To Our Newsletter & Stay Updated
